Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense gemcitabine plus carboplatin in anthracycline- and taxane-resistant advanced breast cancer
2005-005164-83Phase 2Terminated
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Apr 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and carboplatin in breast cancer, sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Overall response rate. Started Apr 2006; status: terminated.
02
Drugs
gemcitabinecarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-005164-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005164-83.